132 related articles for article (PubMed ID: 1473988)
1. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
[TBL] [Abstract][Full Text] [Related]
2. Production of new anthracycline antibiotics by microbial 4-O-methylation using a specific daunorubicin-negative mutant.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Takeuchi T
J Antibiot (Tokyo); 1992 Dec; 45(12):1837-47. PubMed ID: 1490874
[TBL] [Abstract][Full Text] [Related]
3. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
[TBL] [Abstract][Full Text] [Related]
4. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
[TBL] [Abstract][Full Text] [Related]
5. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization.
Yoshimoto A; Johdo O; Fujii S; Kubo K; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1992 Aug; 45(8):1255-67. PubMed ID: 1399846
[TBL] [Abstract][Full Text] [Related]
6. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer.
Fujii S; Kubo K; Johdo O; Yoshimoto A; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Mar; 39(3):473-5. PubMed ID: 3700249
[No Abstract] [Full Text] [Related]
7. Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.
Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1130-40. PubMed ID: 1955396
[TBL] [Abstract][Full Text] [Related]
8. Microbial conversion of anthracyclinones to carminomycins by a blocked mutant of Actinomadura roseoviolacea.
Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
J Antibiot (Tokyo); 1989 Nov; 42(11):1698-703. PubMed ID: 2584152
[TBL] [Abstract][Full Text] [Related]
9. Maggiemycin and anhydromaggiemycin: two novel anthracyclinone antitumor antibiotics. Isolation, structures, partial synthesis and biological properties.
Pandey RC; Toussaint MW; McGuire JC; Thomas MC
J Antibiot (Tokyo); 1989 Nov; 42(11):1567-77. PubMed ID: 2584139
[TBL] [Abstract][Full Text] [Related]
10. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1155-9. PubMed ID: 1955397
[No Abstract] [Full Text] [Related]
12. Anthracycline metabolites from Streptomyces violaceus A262. V. New anthracycline alldimycin A: a minor component isolated from obelmycin beer.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1160-4. PubMed ID: 1955398
[No Abstract] [Full Text] [Related]
13. Production of new anthracycline antibiotic betaclamycin B by microbial conversion with a specific aclacinomycin-negative mutant.
Yoshimoto A; Johdo O; Watanabe Y; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1992 Jun; 45(6):1005-7. PubMed ID: 1500340
[No Abstract] [Full Text] [Related]
14. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
[No Abstract] [Full Text] [Related]
15. Biosynthesis of anthracyclinones.
Eckardt K; Wagner C
J Basic Microbiol; 1988; 28(1-2):137-44. PubMed ID: 3171921
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262.
Johdo O; Ishikura T; Yoshimoto A; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1110-20. PubMed ID: 1955394
[TBL] [Abstract][Full Text] [Related]
17. Structural studies on avidinorubicin, a novel anthracycline with platelet aggregation inhibitory activity.
Aoki M; Shirai H; Nakayama N; Itezono Y; Mori M; Satoh T; Ohshima S; Watanabe J; Yokose K; Seto H
J Antibiot (Tokyo); 1991 Jun; 44(6):635-45. PubMed ID: 2071489
[TBL] [Abstract][Full Text] [Related]
18. Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.
Cassinelli G; Grein A; Masi P; Suarato A; Bernardi L; Arcamone F; Di Marco A; Casazza AM; Pratesi G; Soranzo C
J Antibiot (Tokyo); 1978 Mar; 31(3):178-84. PubMed ID: 649513
[TBL] [Abstract][Full Text] [Related]
19. A new anthracycline antibiotic SN-706.
Kimura K; Koyama T; Nakayama S; Tamura K; Miyata N; Kawanishi G
J Antibiot (Tokyo); 1988 Dec; 41(12):1918-21. PubMed ID: 3209485
[No Abstract] [Full Text] [Related]
20. Microbial conversion of epsilon-pyrromycinone to 1-hydroxy-11-deoxycarminomycin II.
Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
J Antibiot (Tokyo); 1985 Jun; 38(6):821-2. PubMed ID: 4019326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
